abstract |
The invention relates to the use of specific 5-HT 4 receptor agonist compounds for the treatment of cognitive disorders, in particular, to the use of these compounds in combination with other agents, specifically acetylcholinesterase inhibitors, for the treatment of Alzheimer's disease and other cognitive disorders. |